<DOC>
	<DOCNO>NCT02171182</DOCNO>
	<brief_summary>The aim study monitor effectiveness use dosage 8 % capsaicin patch real-life clinical practice treatment post-operative neuropathic pain .</brief_summary>
	<brief_title>A Study Efficacy Safety Qutenza Patients With Post-operative Peripheral Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>diagnosed peripheral postoperative neuropathic pain hypersensitivity capsaicin pregnancy diabetes mellitus treatment face</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Qutenza</keyword>
	<keyword>8 % capsaicin patch</keyword>
	<keyword>Non-interventional</keyword>
	<keyword>Post-operative peripheral neuropathic pain</keyword>
	<keyword>Observational</keyword>
	<keyword>Czech Republic</keyword>
</DOC>